Taja Barber

Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: The CAPTURE study

Robin L. Jones, L. Pickering, C. Swanton, 2021, Nature Cancer.

Immune responses following third COVID-19 vaccination are reduced in patients with hematological malignancies compared to patients with solid cancer

L. Pickering, C. Swanton, K. Edmonds, 2021, Cancer Cell.

Omicron neutralising antibodies after third COVID-19 vaccine dose in patients with cancer

L. Pickering, C. Swanton, K. Edmonds, 2022, The Lancet.

Functional immune responses against SARS-CoV-2 variants of concern after fourth COVID-19 vaccine dose or infection in patients with blood cancer

L. Pickering, K. Edmonds, S. Gamblin, 2022, Cell Reports Medicine.

Immune responses following third COVID-19 vaccination are reduced in patients with hematological malignancies compared to patients with solid cancer

L. Pickering, C. Swanton, K. Edmonds, 2021, Cancer Cell.

Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: The CAPTURE study

Lucy J. Holt, Robin L. Jones, L. Pickering, 2021, Nature Cancer.